Forest plot for the significant MR association between four mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

Subjects:

Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

Subjects:

Risk of bias summary. by Duc Tran Quang (20564967)

Mendelian randomization analyses for the relevance of anti-H. pylori IgG seropositivity with risk of CHD. by Jing Wang (6206297)

Subjects:

Three essential assumptions of the Mendelian randomization study. by Jing Wang (6206297)

Subjects:

Mendelian randomization analysis of the effect of anti-H. pylori IgG seropositivity on coronary heart disease (CHD). by Jing Wang (6206297)

Subjects:

Results data from this Mendelian randomization study. by Jing Wang (6206297)

Subjects:

Associations of anti-H. pylori IgG seropositivity with mediators. by Jing Wang (6206297)

Subjects:

Details of the GWAS data in this study. by Jing Wang (6206297)

Subjects:

Assessment of study bias in the included research. by Junyin Pan (20700411)

Risk of bias assessment for eligible randomized controlled trials. by Junyin Pan (20700411)

Publication bias of the risk of all groups. by Juan Gu (288925)

“…A fixed-effects model was applied if P > 0.1 and I² ≤ 50%; otherwise, a random-effects model was used to account for significant heterogeneity Publication bias was assessed using funnel plots and Egger’s test. …”

Risk of bias. by Da Huang (1306407)

“…The certainty of the evidence assessed according to the GRADE guidelines was moderate and very low, with key factors such as publication bias, imprecision, and inconsistency leading to its downgrading.…”

The influencing factors of RLM. by Yi Yu (28902)

Overall risk of bias assessment. by Da Huang (1306407)

“…The certainty of the evidence assessed according to the GRADE guidelines was moderate and very low, with key factors such as publication bias, imprecision, and inconsistency leading to its downgrading.…”

Risk of bias assessment of included studies. by Imane Salmam (21485704)

Concurrent mixed methods design diagram. by Esario IV Daguman (21474116)

“…It is hypothesised that: a) intervention sites will demonstrate more significant decreases in restrictive practice events and duration and physical injuries, compared to within-group baseline and control group, and b) measures of people’s experiences and perceptions and nurses’ outcomes and behaviours will improve, compared to within-group baseline. …”

The guiding map. by Esario IV Daguman (21474116)

“…It is hypothesised that: a) intervention sites will demonstrate more significant decreases in restrictive practice events and duration and physical injuries, compared to within-group baseline and control group, and b) measures of people’s experiences and perceptions and nurses’ outcomes and behaviours will improve, compared to within-group baseline. …”

Bias risk assessment of included studies. by Xuqin Du (8803772)

“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO₂ (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO₂ (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”

Genetic and structural factors contributing to the dominance and persistence of goose astrovirus type 2 by Peng Jiang (16544)

“…This study explored the genetic and structural factors underlying the prevalence of GoAstV-2, focusing on codon usage bias, spike protein variability, and structural stability. …”